Literature DB >> 24125753

Self-collecting a cervico-vaginal specimen for cervical cancer screening: an exploratory study of acceptability among medically underserved women in rural Appalachia.

Robin C Vanderpool1, Maudella G Jones2, Lindsay R Stradtman3, Jennifer S Smith4, Richard A Crosby3.   

Abstract

OBJECTIVE: Innovative screening methods such as self-testing for human papillomavirus (HPV) may alleviate barriers to cervical cancer screening. The purpose of this exploratory study was to determine whether Appalachian Kentucky women would be amenable to self-collecting a cervico-vaginal specimen for HPV testing.
METHODS: Women aged 30-64 who were overdue for guideline-recommended cervical cancer screening were recruited from a primary care clinic in southeastern Kentucky. The women were asked to self-collect a specimen, using a cervico-vaginal brush, based on verbal and printed directions provided by a research nurse. All study participants, regardless of laboratory-confirmed HPV status, received the same counseling on the importance of cervical cancer screening and offered navigation to follow-up Pap testing at the local health department.
RESULTS: Thirty-one women were approached and recruited to participate in the study, indicating a 100% acceptance rate of HPV self-testing. Of the 31 women, 26 tested negative for high-risk HPV and five tested positive. All of the women with negative results declined nurse navigation to Pap testing, whereas four of the five women with positive results accepted nurse navigation and received subsequent Pap smear screenings (all results were normal).
CONCLUSIONS: Among this sample of Appalachian Kentucky women, self-collecting a cervico-vaginal specimen for HPV testing was highly acceptable. This exploratory study provides impetus for larger studies among high-risk, medically underserved women in rural communities. Tailoring alternative cancer screening strategies to meet the complex needs of rural women is likely to lead to reductions in cervical cancer incidence and mortality among this vulnerable population.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acceptance; Appalachia; Cervical cancer; HPV testing; Patient navigation

Mesh:

Year:  2013        PMID: 24125753      PMCID: PMC4753797          DOI: 10.1016/j.ygyno.2013.10.008

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  33 in total

1.  Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.

Authors:  Steven S Coughlin; Trevor D Thompson; H Irene Hall; Pamela Logan; Robert J Uhler
Journal:  Cancer       Date:  2002-06-01       Impact factor: 6.860

Review 2.  Geographic disparities in cervical cancer mortality: what are the roles of risk factor prevalence, screening, and use of recommended treatment?

Authors:  K Robin Yabroff; William F Lawrence; Jason C King; Patricia Mangan; Kathleen Shakira Washington; Bin Yi; Jon F Kerner; Jeanne S Mandelblatt
Journal:  J Rural Health       Date:  2005       Impact factor: 4.333

3.  Key informants' perspectives prior to beginning a cervical cancer study in Ohio Appalachia.

Authors:  Mira L Katz; Mary Ellen Wewers; Nancy Single; Electra D Paskett
Journal:  Qual Health Res       Date:  2007-01

4.  Variability of cervical cancer rates across 5 Appalachian states, 1998-2003.

Authors:  Claudia Hopenhayn; Jessica B King; Amy Christian; Bin Huang; W Jay Christian
Journal:  Cancer       Date:  2008-11-15       Impact factor: 6.860

5.  Cancer incidence in Kentucky, Pennsylvania, and West Virginia: disparities in Appalachia.

Authors:  Eugene J Lengerich; Thomas C Tucker; Raymond K Powell; Pat Colsher; Erik Lehman; Ann J Ward; Jennifer C Siedlecki; Stephen W Wyatt
Journal:  J Rural Health       Date:  2005       Impact factor: 4.333

6.  Smoking and cervical cancer: pooled analysis of the IARC multi-centric case--control study.

Authors:  Martyn Plummer; Rolando Herrero; Silvia Franceschi; Chris J L M Meijer; Peter Snijders; F Xavier Bosch; Silvia de Sanjosé; Nubia Muñoz
Journal:  Cancer Causes Control       Date:  2003-11       Impact factor: 2.506

7.  An in-depth and updated perspective on determinants of cervical cancer screening among central Appalachian women.

Authors:  Nancy E Schoenberg; Claudia Hopenhayn; Amy Christian; Evelyn A Knight; Angel Rubio
Journal:  Women Health       Date:  2005

8.  Cancer in Appalachia, 2001-2003.

Authors:  Phyllis A Wingo; Thomas C Tucker; Patricia M Jamison; Howard Martin; Colleen McLaughlin; Rana Bayakly; Susan Bolick-Aldrich; Pat Colsher; Robert Indian; Karen Knight; Stacey Neloms; Reda Wilson; Thomas B Richards
Journal:  Cancer       Date:  2008-01-01       Impact factor: 6.860

9.  Cancer death rates--Appalachia, 1994-1998.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-06-21       Impact factor: 17.586

10.  Assessing awareness and knowledge of breast and cervical cancer among Appalachian women.

Authors:  Nikki L Lyttle; Kelly Stadelman
Journal:  Prev Chronic Dis       Date:  2006-09-15       Impact factor: 2.830

View more
  22 in total

1.  Effects of an Education Intervention about HPV Self-Testing for Healthcare Providers and Staff.

Authors:  Brynne E Presser; Mira L Katz; Abigail B Shoben; Deborah Moore; Mack T Ruffin; Electra D Paskett; Paul L Reiter
Journal:  J Cancer Educ       Date:  2018-10       Impact factor: 2.037

Review 2.  Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: Focused literature review.

Authors:  Tina R Madzima; Mandana Vahabi; Aisha Lofters
Journal:  Can Fam Physician       Date:  2017-08       Impact factor: 3.275

3.  Community-Based Screening for Cervical Cancer: A Feasibility Study of Rural Appalachian Women.

Authors:  Richard A Crosby; Michael E Hagensee; Robin Vanderpool; Nia Nelson; Adam Parrish; Tom Collins; Nebraska Jones
Journal:  Sex Transm Dis       Date:  2015-11       Impact factor: 2.830

4.  Results of a Pilot Study of a Mail-Based Human Papillomavirus Self-Testing Program for Underscreened Women From Appalachian Ohio.

Authors:  Paul L Reiter; Abigail B Shoben; Deborah McDonough; Mack T Ruffin; Martin Steinau; Elizabeth R Unger; Electra D Paskett; Mira L Katz
Journal:  Sex Transm Dis       Date:  2019-03       Impact factor: 2.830

5.  Psychosocial Correlates of Ever Having a Pap Test and Abnormal Pap Results in a Sample of Rural Appalachian Women.

Authors:  Kristen P Mark; Richard A Crosby; Robin C Vanderpool
Journal:  J Rural Health       Date:  2017-09-05       Impact factor: 4.333

6.  Clinician and Patient Acceptability of Self-Collected Human Papillomavirus Testing for Cervical Cancer Screening.

Authors:  Constance Mao; Shalini L Kulasingam; Hilary K Whitham; Stephen E Hawes; John Lin; Nancy B Kiviat
Journal:  J Womens Health (Larchmt)       Date:  2017-03-23       Impact factor: 2.681

7.  Cervical cancer screening (Pap testing) behaviours and acceptability of human papillomavirus self-testing among lesbian and bisexual women aged 21-26 years in the USA.

Authors:  Paul L Reiter; Annie-Laurie McRee
Journal:  J Fam Plann Reprod Health Care       Date:  2014-11-10

8.  Preference for Human Papillomavirus Self-Collection and Papanicolaou: Survey of Underscreened Women in North Carolina.

Authors:  Kimberly A Kilfoyle; Andrea C Des Marais; Mai Anh Ngo; LaHoma Romocki; Alice R Richman; Lynn Barclay; Noel T Brewer; Lisa Rahangdale; Jennifer S Smith
Journal:  J Low Genit Tract Dis       Date:  2018-10       Impact factor: 1.925

9.  Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.

Authors:  Cary Suzanne Lea; Carolina Perez-Heydrich; Andrea C Des Marais; Alice R Richman; Lynn Barclay; Noel T Brewer; Jennifer S Smith
Journal:  J Womens Health (Larchmt)       Date:  2019-03-15       Impact factor: 2.681

Review 10.  A Social-Ecological Review of Cancer Disparities in Kentucky.

Authors:  Sharon D Rodriguez; Nathan L Vanderford; Bin Huang; Robin C Vanderpool
Journal:  South Med J       Date:  2018-04       Impact factor: 0.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.